麻豆传媒

Ellen Peters is an academic expert in decision making and the science of science communication. Her primary research interests concern how people judge and decide, and how evidence-based communication can boost comprehension and improve decisions in health, financial, and environmental contexts. She is especially interested in the basic building blocks of human judgment and decision making鈥攕uch as emotions and number abilities鈥攁nd their links to effective communication techniques. These processes are also central to the effects of adult aging on decision making as well as to public policy issues, such as how to communicate about the health effects of smoking or about the pros and cons of cancer screenings and treatments. She is also interested in methods to increase number ability, a.k.a. numeracy, to improve decision making and, in turn, health and financial outcomes. 

As Philip H. Knight Chair, Director of the Center for Science Communication Research (SCR), and Professor in both the School of Journalism and Communication and the Psychology Department at the University of Oregon, she explores how policy makers, physicians, and other experts can enhance public understanding of science and technology by advancing the science of science communication.

Her book, Innumeracy in the Wild: Misunderstanding and Misusing Numbers, was published by Oxford University Press. 

Jonathan Leventhal, MD, is the director of the Onco-Dermatology Program at Smilow Cancer Hospital at Yale New Haven. He treats patients undergoing cancer treatment who experience itchy or painful rashes, as well as hair and nail changes that can result from either their disease or treatment, including chemotherapy, immunotherapy, radiation or stem cell transplantation.
鈥淥ne of the most rewarding aspects of my job is improving the quality of life for patients with cancer who are affected by adverse skin events,鈥� he says.
Seeing an onco-dermatologist like Dr. Leventhal can make the difference between a patient being able to continue receiving a cancer treatment or having to be taken off it when the skin conditions become too severe. 鈥淚f left untreated, some skin, hair and nail conditions can become quite debilitating, even disfiguring and may negatively impact health and ability to perform day-to-day activities,鈥� says Dr. Leventhal. He helps to manage these skin problems so that patients with cancer can continue their treatments and enjoy a better quality of life.
In addition to his role at Smilow, Dr. Leventhal, an associate professor of dermatology and associate director of the residency program at Yale School of Medicine, cares for patients with a wide range of skin conditions in Yale Medicine Dermatology鈥檚 New Haven and Branford locations. He performs routine skin cancer screening examinations and also treats general skin problems鈥攆rom acne to psoriasis to eczema. He is also the Associate Residency Program Director and is Principal Investigator of several clinical trials involving the management of cutaneous reactions to cancer therapy.
"Every day I am excited to come to work, treating various skin conditions affecting my patients and helping patients with cancer continue their potentially life-saving treatments,鈥� says Dr. Leventhal. 鈥淪kin diseases can impact the way people see themselves and can affect how people feel, both physically and emotionally. My work is particularly gratifying when I can improve my patients' overall comfort, happiness and health.鈥�

Education & Training:
Resident- Yale University School of Medicine (2016)
Intern- NYU Langone Hospital - Long Island (2013)
MD- New York University (2012)

Honors & Recognition:
2018 Medical Education Fellowship
2015 Hugh L. Dwyer Memorial Fund Award for Clinical Excellence

Pinunta Nittayacharn received her B.Eng and M.Eng in Biomedical Engineering from Mahidol University, in Salaya, Thailand, in 2011 and 2014 with research distinction in biopolymer and local drug delivery systems for cancer treatment. After graduation, Pinunta held a position as a full time researcher and lecturer at the Department of Biomedical Engineering, Mahidol University, for two years. She is currently pursuing a doctorate in Biomedical Engineering at Case Western Reserve University in Cleveland, OH and is supported by a scholarship from the Royal Thai Government. She joined Professor Agata Exner鈥檚 lab in the Fall of 2016 as a Ph.D. student and is currently a fourth-year Ph.D. candidate. She has started to focus on her new research interests about developing drug-loaded nano-scale ultrasound contrast agents (nanobubbles) for image-guided and drug delivery in cancer treatment. Enhancements in drug accumulation and penetration will allow for greater therapeutic efficiency of cancers. In particular, she works on improving the drug loading capacity of nanobubbles. This approach has great potential for maximizing the treatment directly at the tumor site while minimizing systemic side effects.